Delay in Clozapine Initiation in Patients with Treatment-Resistance  Schizophrenia Presenting Tertiary Psychiatric Facilities

Authors

  • Asad Ullah Jan Department of Psychiatry, Combined Military Hospital Nowshera/National University of Medical Sciences (NUMS) Pakistan
  • Sajid Rahim Department of Psychiatry, Combined Military Hospital Peshawar/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74i3.11530

Keywords:

Clozapine initiation, Delay, Treatment-resistant schizophrenia

Abstract

Objective: To determine the delay in Clozapine initiation in patients with treatment-resistance schizophrenia who presented to the Tertiary psychiatric facilities.

Study Design:  Cross-sectional study.

Place and Duration of Study: Department of Psychiatry Combined Military Hospital, Peshawar and Department of Psychiatry Combined Military Hospital, Nowshera Pakistan, from Jan to Dec 2023.

Methodology: We recruited 103 treatment-resistant schizophrenia and Clozapine naïve patients after obtaining their consent. Patients were included by reviewing their medical history and records. The diagnosis was made by clinical interview and use of Positive and Negative syndrome scale. The data were recorded using a semi-structured questionnaire.

Results: Out of 103 patients, 78(75.7%) were male and 25(24.3%) were female. Regarding the initiation of Clozapine treatment, the mean duration from diagnosis to treatment initiation was 6.23±4.82 years. Patients were categorised based on the time to Clozapine initiation into early initiators (≤4 years), intermediate initiators (>4 years to <15 years), and delayed initiators (>15 years). The distribution across these categories was 51(49.5%) for early initiators, 47(45.6%) for intermediate initiators, and 5(4.9%) for delayed initiators.

Conclusion: There is a significant delay in Clozapine initiation despite adequate evidence to initiate it early. Clinicians should start Clozapine whenever there is a need.

Downloads

Download data is not yet available.

References

Nucifora FC, Woznica E, Lee BJ, Cascella N, Sawa A. Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives. Neurobiol Dis 2019; 131: 104257.

https://doi.org/10.1016/J.NBD.2018.08.016

Thien K, O’Donoghue B. Delays and barriers to the commencement of Clozapine in eligible people with a psychotic disorder: A literature review. Early Interv Psychiatry 2019; 13(1): 18-23. https://doi.org/ 10.1111/eip.12683

Hatano M, Kamei H, Takeuchi I, Gomi K, Sakakibara T, Hotta S, et al. Long-term outcomes of delayed Clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study. BMC Psychiatry 2023; 23(1): 673.

https://doi.org/ 10.1186/s12888-023-05176-y

Warnez S, Alessi-Severini S. Clozapine: a review of clinical practice guidelines and prescribing trends. BMC Psychiatry 2014; 14: 102. https://doi.org/10.1186/1471-244X-14-102

Kane J. Clozapine for the Treatment-Resistant Schizophrenic. Arch Gen Psychiatry 1988; 45(9): 789-96.

https://doi.org/ 10.1001/archpsyc.1988.01800330013001

Taylor DM, Young C. Prior antipsychotic prescribing in patients currently receiving Clozapine: a case note review. J Clin Psy-chiatry 2003; 64(1): 30-34. https://doi.org/ 10.4088/jcp.v64n0107

Wheeler AJ, Feetam CL, Harrison J. Pathway to Clozapine Use: A Comparison Between a Patient Cohort from New Zealand and a Cohort from the United Kingdom. Clin Drug Investig 2014; 34(3): 203-211.

https://doi.org/10.1007/s40261-013-0166-x

Iruretagoyena B, Castañeda CP, Mena C, Diaz C, Nachar R, Ramirez-Mahaluf JP, et al. Predictors of Clozapine discontinuation at 2years in treatment-resistant schizophrenia. Schizophr Res 2021: 235: 102-108.

https://doi.org/10.1016/j.schres.2021.07.024

Trinczek E, Heinzel-Gutenbrunner M, Haberhausen M, Bachmann CJ. Time to Initiation of Clozapine Treatment in Children and Adolescents with Early-Onset Schizophrenia. Pharmacopsychiatry 2016; 49: 254–259.

https://doi.org/10.1055/s-0042-116947

Grover S, Hazari N, Chakrabarti S, Avasthi A. Delay in initiation of Clozapine: a retrospective study from a tertiary care hospital in North India. Psychiatry Res 2015; 226: 181–185.

https://doi.org/ 10.1016/j.psychres.2014.12.046

Muñoz-Manchado LI, Perez-Revuelta JI, Banerjee A, Galindo-Guarin L, Bernardo M, González-Saiz F, et al. Influence of time to Clozapine prescription on the clinical outcome. Schizophr Res 2023: S0920-9964(23)00339-0.

https://doi.org/:10.1016/j.schres.2023.09.028

Yoshimura B, Yada Y, So R, Takaki M, Yamada N. The critical treatment window of Clozapine in treatment-resistant schizophrenia: Secondary analysis of an observational study. Psychiatry Res 2017; 250: 65–70.

https://doi.org/10.1016/j.psychres.2017.01.064

Shah P, Iwata Y, Plitman E, Brown EE, Caravaggio F, Kim J, et al. The impact of delay in Clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review. Psychiatry Res 2018; 268: 114–122.

https://doi.org/10.1016/j.psychres.2018.06.070

Jones R, Upthegrove R, Price MJ, Pritchard M, Chandan JS, Legge S, et al. Duration of prior psychotic illness and Clozapine response: a retrospective observational study using electronic health records. Ther Adv Psychopharmacol 2022; 12.

https://doi.org/10.1177/20451253221103353

Chan SKW, Chan HYV, Honer WG, Bastiampillai T, Suen YN, Yeung WS, et al. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders. Schizophr Bull 2021; 47: 485–494.

https://doi.org/ 10.1093/schbul/sbaa145

Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, et al. International trends in Clozapine use: a study in 17 countries. Acta Psychiatr Scand 2017; 136: 37–51.

https://doi.org/10.1111/acps.12742

Xu SW, Dong M, Zhang Q, Yang SY, Chen LY, Sim K, et al. Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016). Psychiatry Res 2020; 287.

https://doi.org/10.1016/j.psychres.2019.02.056

Jones R, MacCabe JH, Price MJ, Liu X, Upthegrove R. Effect of age on the relative efficacy of Clozapine in schizophrenia. Acta Psychiatr Scand 2020; 142: 109–120.

https://doi.org/ 10.1111/acps.13156

Downloads

Published

28-06-2024

Issue

Section

Original Articles

How to Cite

1.
Jan AU, Rahim S. Delay in Clozapine Initiation in Patients with Treatment-Resistance  Schizophrenia Presenting Tertiary Psychiatric Facilities. Pak Armed Forces Med J [Internet]. 2024 Jun. 28 [cited 2024 Nov. 5];74(3):804-7. Available from: https://pafmj.org/PAFMJ/article/view/11530